Causal machine learning for predicting treatment outcomes.

Journal: Nature medicine
PMID:

Abstract

Causal machine learning (ML) offers flexible, data-driven methods for predicting treatment outcomes including efficacy and toxicity, thereby supporting the assessment and safety of drugs. A key benefit of causal ML is that it allows for estimating individualized treatment effects, so that clinical decision-making can be personalized to individual patient profiles. Causal ML can be used in combination with both clinical trial data and real-world data, such as clinical registries and electronic health records, but caution is needed to avoid biased or incorrect predictions. In this Perspective, we discuss the benefits of causal ML (relative to traditional statistical or ML approaches) and outline the key components and steps. Finally, we provide recommendations for the reliable use of causal ML and effective translation into the clinic.

Authors

  • Stefan Feuerriegel
    ETH AI Center, ETH Zurich, Zurich, Switzerland.
  • Dennis Frauen
    LMU Munich, Munich, Germany.
  • Valentyn Melnychuk
    LMU Munich, Munich, Germany.
  • Jonas Schweisthal
    LMU Munich, Munich, Germany.
  • Konstantin Hess
    LMU Munich, Munich, Germany.
  • Alicia Curth
    University of Oxford, Oxford, UK;
  • Stefan Bauer
    Department of Computer Science, ETH Zurich, Zürich, Switzerland.
  • Niki Kilbertus
    Helmholtz Munich, Munich, Germany.
  • Isaac S Kohane
    Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA. Isaac_Kohane@hms.harvard.edu.
  • Mihaela van der Schaar
    University of California, Los Angeles, CA, USA.